Work

Supplementary Table S6 from Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant Mutations

Year: 2025

Type: supplementary-materials

Abstract: Supplementary Table S6: Pharmacokinetics measurements from intracranial Ba/F3 CD74-ROS1 G2032R luciferase study

DOI: 10.1158/1535-7163.29457419

Authors: Anupong Tangpeerachaikul, Scot Mente, Joe Magrino, Franklin Gu, Joshua C. Horan, Henry E. Pelish

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4411966752

Cites:

Cited by:

Related to: 10